Compare STRO & PDLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | STRO | PDLB |
|---|---|---|
| Founded | 2003 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.0M | 405.9M |
| IPO Year | 2018 | 2017 |
| Metric | STRO | PDLB |
|---|---|---|
| Price | $11.69 | $16.31 |
| Analyst Decision | Hold | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $18.29 | N/A |
| AVG Volume (30 Days) | ★ 120.7K | 101.9K |
| Earning Date | 11-06-2025 | 01-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 142.83 |
| EPS | N/A | ★ 0.89 |
| Revenue | ★ $105,646,000.00 | $96,252,000.00 |
| Revenue This Year | $63.08 | $10.97 |
| Revenue Next Year | N/A | $8.59 |
| P/E Ratio | ★ N/A | $18.36 |
| Revenue Growth | N/A | ★ 26.04 |
| 52 Week Low | $5.23 | $10.88 |
| 52 Week High | $21.50 | $18.01 |
| Indicator | STRO | PDLB |
|---|---|---|
| Relative Strength Index (RSI) | 79.96 | 50.21 |
| Support Level | $8.49 | $16.87 |
| Resistance Level | $12.00 | $17.48 |
| Average True Range (ATR) | 0.84 | 0.47 |
| MACD | -0.05 | -0.12 |
| Stochastic Oscillator | 84.03 | 6.90 |
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.